Susquehanna Fundamental Investments, LLC Inmune Bio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.42 - $11.39 $80,076 - $142,067	-12,473 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.97 - $20.38 $47,128 - $96,336	-4,727 Reduced 27.48%	12,473 $127,000
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $243,036 - $479,020	17,200 New	17,200 $334,000
Q2 2021 Aug 11, 2021	SELL	$9.29 - $19.33 $126,929 - $264,105	-13,663 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.61 - $26.85 $1,497 - $3,463	129 Added 0.95%	13,663 $162,000
Q4 2020 Feb 16, 2021	SELL	$7.51 - $17.22 $95,872 - $219,830	-12,766 Reduced 48.54%	13,534 $233,000
Q3 2020 Nov 16, 2020	BUY	$4.92 - $15.75 $129,396 - $414,225	26,300 New	26,300 $271,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.